Etoricoxib

CAS 202409-33-4

Overview

Etoricoxib, sold under the trade name Arcoxia, is a selective COX-2 inhibitor from McOLSON Research Laboratories

Anant Labs manufacture and furnish high quality Etoricoxib impurities for global markets. Our Etoricoxib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Etoricoxib

Cat. No. ANTPRD1171Old No. ANT-ETR-00CAS 202409-33-4In Stock

Technical Data

New Cat. No.ANTPRD1171

Old Cat. No.ANT-ETR-00

CAS202409-33-4

Mol. FormulaC₁₈H₁₅ClN₂O₂S

Mol. Weight358.84 g/mol

IUPAC5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine

SMILESCC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C

InChIInChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3

InChI KeyMNJVRJDLRVPLFE-UHFFFAOYSA-N

Synonyms

5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridineEtoricoxib202409-33-4ArcoxiaMK-06635-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridineL-7914565-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridineetoricoxibumMK0663